It has been shown experimentally that oral absorption of phylloquinone (vitamin K~1~; K~1~) is higher when it is taken as a pharmaceutical preparation than when it is taken as part of a meal in which the vitamin is naturally present ([@CIT0001]). Dietary K~1~ as well as the closely related menaquinone-4 (MK-4) are transported with different lipoproteins in the blood ([@CIT0002]). Different tissues have different mechanisms of uptake of vitamin-carrying plasma proteins, resulting in differences in the equilibrium concentrations of K~1~ and MK-4 ([@CIT0003], [@CIT0004]). There is also evidence that MK-4 can be synthesized in tissues from menadione (vitamin K~3~; K~3~), either as such ([@CIT0005]), derived from K~1~ ([@CIT0006]--[@CIT0009]), or by direct substitution ([@CIT0010]). In many of these studies the experimental animals were deprived of vitamin K or given overly high doses of K~1~.

Chickens have been bred for high utilization of feed and high rates of growth. During the first 3 weeks of life a typical chicken will increase its body mass by a factor of 20. Chickens cannot perform *de novo* synthesis of vitamin K; hence the tissue levels of vitamin K measured after the feeding period would in some way have to be related to the dietary intake. Any vitamin K present at the start of experimental feeding would provide only a limited fraction of the total amount present. Liver is the main site of synthesis for vitamin K-dependent coagulation factors and has been shown to possess the apparatus necessary to synthesize MK-4 ([@CIT0005], [@CIT0007], [@CIT0009]). Pancreas has been reported to have higher values of MK-4 than most other tissues, possibly owing to K~1~-to-MK-4 conversion ([@CIT0011], [@CIT0012]) and possibly related to the secretion of MK-4 in pancreatic juice ([@CIT0013]). In chickens, the activity of epoxide reductase per gram tissue has been found to be 10% of the activity in rats ([@CIT0006]), explaining why a high proportion of the vitamin K material of chickens is present as the 2,3-epoxide.

The present study was designed to investigate how ordinary dietary doses of vitamin K would influence tissue accumulation of K~1~ and MK-4. Care was taken to vary only the dietary concentration of MK-4 together with an adequate and stable concentration of K~1~, and in an identical feed matrix so as to limit any feed-induced variations in bioavailability. For comparison regarding the adequacy of the feeds a control group receiving the standard chicken feed containing additional K~3~ was included.

Vitamin K--dependent carboxylation of bone matrix proteins is regarded as important for bone matrix calcification ([@CIT0014]). Bone strength was measured to investigate whether our modest variations in vitamin K content could be detected in this system.

Methods {#S0001}
=======

Chickens {#S20002}
--------

Fifty-seven newly hatched male chickens (Samvirke kylling Norway, Ross 308) from the same hatching farm were used in this experiment conducted at The Norwegian University of Life Sciences. Animal treatment and animal facilities all complied with the Guide for the Care and Use of Laboratory Animals ([@CIT0015]). The experimental animal research followed internationally recognized guidelines. All animals were cared for according to Norwegian laws and regulations for experiments with live animals (The Animal Protection Act of December 20th, 1974, and the Animal Protection Ordinance Concerning Experiments with Animals of January 15th, 1996).

Experimental design {#S20003}
-------------------

The chickens were randomly assigned into one of four dietary 22 day treatments. During the first 10 days each group of 14 to 15 animals were kept in deep littered pens; 75 cm×150 cm. At day 10 they were weighed and individually placed in wire-floored metabolism cages up until day 22. The chickens were raised in an environmentally controlled room. The room temperature was maintained at 32°C from days 0--3, then gradually reduced by 0.5°C per day until day 22. They were exposed to 23 h light and 1 h dark photoperiod days 0--7, the next 2 weeks they were exposed to 2×4 h dark; the dark periods were between 17--21 h and 00--04 h. The chickens had free access to feed and water. Water troughs and wire-floors were cleaned daily, with small possibility of coprophagy. Feed intake and body weight were registered day 11 to day 22. None of the birds were sick or died during the feeding period.

Sampling {#S20004}
--------

At day 22 the chickens were weighed, killed by carbon dioxide narcosis and dissected immediately after death. Organs and limbs were packed in aluminum foil, frozen in liquid nitrogen and stored at −20°C before being analyzed.

Vitamin K in diets {#S20005}
------------------

Rapeseed oil was purchased from AFB, Askim, Norway and contained 60% oleic acid, 20% linoleic acid and 10% alpha linolenic acid. Rendered animal fat (RAF) was obtained locally and contained fat from ruminants (about 70%) and pigs (about 30%). The composition of RAF was (by weight): 26% palmitic acid, 18% stearic acid, 36% oleic acid and 8% linoleic acid. Fully hydrogenated soybean oil (HSO), refined to remove K~1~ and ineffective dihydrophylloquinone together with *trans*-fatty acids, were purchased from AAK (Aarhus-Karlshamn) Sweden AB. The level of K~1~ in HSO was less than 10% of the original amount in untreated soybean oil. dihydrophylloquinone was not detected in the oils.

All four feeds were wheat based and composed according to guidelines adjusted to the requirements of chickens ([Table 1](#T0001){ref-type="table"}). The feeds were manufactured at ForTek, Aas, Norway, with a matrix type 2.5 mm×46 mm at a rate of 600 kg/h. They had the same basic composition with regard to protein, carbohydrates, minerals and vitamins except vitamin K. All diets contained lipid in the form of oils and solid fats. The control (CTR) feed group contained vitamin K~1~ from rapeseed oil and soy bean oil; MK-4 from RAF and added K~3~. The experimental feeds contained natural levels of K~1~ and MK-4 from RAF, fully HSO or a mixture of animal rendered fat and fully HSO (MIX). The experimental diets contained 2% natural soybean oil to provide a small supplement of K~1~ ([Table 1](#T0001){ref-type="table"}). K~1~ content of the control diet was 32% higher than the experimental feeds. The experimental feeds had MK-4 levels from 20 to 50% of the K~1~ level.

###### 

Composition of the experimental feeds including levels of vitamin K

  Ingredients                                            CTR     MIX     RAF     HSO
  ------------------------------------------------------ ------- ------- ------- -------
  Wheat (%)                                              60      60      60      60
  Soybean meal (%)                                       20      20      20      20
  Fish meal (%)                                          3       3       3       3
  Rapeseed oil (%)                                       5       0       0       0
  Animal Rendered fat (%)                                5       4       8       0
  Soybean oil (%)                                        0       2       2       2
  Hydrogenated soybean oil (%)                           0       4       0       8
  Mineral mixture[a](#TF0001){ref-type="table-fn"} (%)   0.15    0.15    0.15    0.15
  Vitamin mixture[a](#TF0001){ref-type="table-fn"} (%)   0.08    0.08    0.08    0.08
  MK-4 (ng/g feed)                                       75.3    62.5    51.6    22.6
  K~1~ (ng/g feed)                                       157.2   120.4   119.8   119.1
  K~3~ ( ng/g feed)                                      2,250   --      --      --

Notes: All feeds contained Monocalcium phosphate 2%; Ground limestone 1.85%; NaCl 0.25%; DL-Methionine 0.4%, L-lysine 0.3%; L-Threonine 0.1%; Choline chloride 0.13% and MgO 6.57×10^−3^%.

Vitamin and mineral mixture provided the following per kg feed: retinyl acetate, 2.7 mg; cholecalsiferol, 0.07 mg; DL-alpha tocopheryl acetate, 38 mg; pyridoxine, 3.4 mg; riboflavin, 9 mg; Ca-pantothenate, 12.5 mg; biotin, 0.19 mg; thiamine, 1.9 mg; niacin, 37.5 mg; cobalamine, 0.02 mg; folic acid, 1.5 mg; choline chloride, 500 mg; manganese, 75 mg; zinc, 75 mg; iron, 95 mg; cupper, 10 mg; iodine, 0.6 mg; selenium, 0.43 mg.

Vitamin K analysis {#S20006}
------------------

Vitamin K in liver, pancreas and feeds were analyzed by HPLC using a C-18 reversed phase column and fluorometric detection after postcolumn electrochemical reduction according to Thijssen et al. ([@CIT0016]).

Testing of bone strength {#S20007}
------------------------

The right femur was thawed gently and dissected free of muscle. Bending resistance was tested in a TA-XT2 texture analyzer from Stable Micro Systems, Godalming, Surrey, UK ([www.stablemicrosystems.com](http://www.stablemicrosystems.com)). Probe velocity was at 0.1 mm/s, and the distance between the supports was 32.5 mm. Load-versus-time curves were generated and analyzed by means of Texture Expert Exceed v2.64 software. Bending resistance was calculated from the initial linear segment of the graphs and expressed as N/mm.

Statistical analyses {#S20008}
--------------------

Statistical calculations (linear regression) on the effect of the four dietary treatments were performed by SPSS 15.0 IBM SPSS, Statistical Analyses Software (<http://www.spss.com/>), using comparative means by one-way ANOVA and Bonferroni test for assumption of equal variances.

Results {#S0009}
=======

Chicken growth {#S20010}
--------------

Weight at day 11 and 22 showed that the chickens in the experimental groups ate slightly more and the RAF and HSO group grew significantly faster than the MIX and CTR groups indicating a satisfactory nutritional status ([Table 2](#T0002){ref-type="table"}).

###### 

Information on feed and weight of the chicken from day 11 to day 22

                              CTR                                             MIX                                           RAF                                           HSO
  --------------------------- ----------------------------------------------- --------------------------------------------- --------------------------------------------- -----------------------------------------------
  n=number of chickens        15                                              14                                            14                                            14
  Chicken weight day 11 (g)   268 (18)[a,c,d](#TF0002){ref-type="table-fn"}   243 (13)[b,d](#TF0002){ref-type="table-fn"}   274 (16)[a,c](#TF0002){ref-type="table-fn"}   256 (13)[a,b,d](#TF0002){ref-type="table-fn"}
  Chicken weight day 22 (g)   800 (84)[a](#TF0002){ref-type="table-fn"}       827 (48)[a](#TF0002){ref-type="table-fn"}     939 (68)[b](#TF0002){ref-type="table-fn"}     936 (63)[b](#TF0002){ref-type="table-fn"}
  Liver weight (g)            28 (3)[a,b](#TF0002){ref-type="table-fn"}       27 (3)[a](#TF0002){ref-type="table-fn"}       30 (3)[b](#TF0002){ref-type="table-fn"}       30 (5)[b](#TF0002){ref-type="table-fn"}
  Feed intake (g)             680 (72)[a](#TF0002){ref-type="table-fn"}       701 (41)[a,b](#TF0002){ref-type="table-fn"}   746 (51)[b](#TF0002){ref-type="table-fn"}     766 (64)[b](#TF0002){ref-type="table-fn"}
  K~1~ intake (µg)            107 (11)[a](#TF0002){ref-type="table-fn"}       84 (5)[b](#TF0002){ref-type="table-fn"}       90 (6)[b](#TF0002){ref-type="table-fn"}       92 (8)[b](#TF0002){ref-type="table-fn"}
  MK-4-intake (µg)            51 (5)[a](#TF0002){ref-type="table-fn"}         44 (3)[b](#TF0002){ref-type="table-fn"}       38 (3)[c](#TF0002){ref-type="table-fn"}       17 (1)[d](#TF0002){ref-type="table-fn"}
  K~1~ intake (µg)            1,530                                                                                                                                       

Notes: Values are means and SD.

Means with different letters within the same row are significantly different at the 5% level.

Total amount of MK-4 eaten by the chicken was significantly different, being highest in the CTR group and lowest in the HSO group, while for K~1~ no difference between experimental group but significantly higher in the control group ([Table 2](#T0002){ref-type="table"}).

Vitamin K in liver and pancreas {#S20011}
-------------------------------

Pancreas had higher vitamin K concentration than liver ([Table 3](#T0003){ref-type="table"}). In liver, MK-4 was the most abundant vitamer, while in pancreas MK-4O was the main vitamer. K~1~ was not detected in pancreas ([Table 3](#T0003){ref-type="table"}). The association between the amounts of MK-4 consumed and MK-4 in liver was statistically significant.

###### 

Levels of vitamin K in liver and pancreas and femur bending resistance

                              CTR                                            MIX                                          RAF                                          HSO
  --------------------------- ---------------------------------------------- -------------------------------------------- -------------------------------------------- --------------------------------------------
  *Liver*                                                                                                                                                              
  K~1~ (ng/g)                 47 (11)[a](#TF0003){ref-type="table-fn"}       28 (11)[b](#TF0003){ref-type="table-fn"}     35 (16)[a](#TF0003){ref-type="table-fn"}     26 (12)[b](#TF0003){ref-type="table-fn"}
  MK-4 (ng/g)                 425 (66)[a](#TF0003){ref-type="table-fn"}      238 (56)[b](#TF0003){ref-type="table-fn"}    105 (22)[c](#TF0003){ref-type="table-fn"}    59 (14)[d](#TF0003){ref-type="table-fn"}
  MK-4O (ng/g)                104 (29)[a](#TF0003){ref-type="table-fn"}      80 (25)[b](#TF0003){ref-type="table-fn"}     38 (16)[c](#TF0003){ref-type="table-fn"}     23 (16)[d](#TF0003){ref-type="table-fn"}
  MK-4/(MK-4+MK-4O)%          75 (9)                                         66 (11)                                      64 (14)                                      63 (20)
  *Pancreas*                                                                                                                                                           
  MK-4O (ng/g)                1,158 (617)[a](#TF0003){ref-type="table-fn"}   522 (351)[b](#TF0003){ref-type="table-fn"}   316 (186)[c](#TF0003){ref-type="table-fn"}   118 (61)[d](#TF0003){ref-type="table-fn"}
  MK-4 (ng/g)                 59 (86)                                        32 (49)                                      7 (9)                                        11 (9)
  MK-4/(MK-4+MK-4O)%          *5* (13)                                       6 (13)                                       2 (4)                                        9 (9)
  *Femur*                                                                                                                                                              
  Bending resistance (N/mm)   85 (10)[a](#TF0003){ref-type="table-fn"}       96 (13)[b](#TF0003){ref-type="table-fn"}     98 (11)[b](#TF0003){ref-type="table-fn"}     102 (12) [b](#TF0003){ref-type="table-fn"}

Notes: Values are means and SD.

Means with different letters within the same row are significantly different at the 5% level.

The concentration of total MK-4 and MK-4O in pancreas as well as in liver is associated with MK-4 consumed.

Bone strength {#S20012}
-------------

The bending resistance of the femur was slightly higher in the experimental groups than in the control group, with no difference between the experimental groups ([Table 3](#T0003){ref-type="table"}).

Discussion {#S0013}
==========

It has long been known that MK-4 is being synthesized in tissues of animals. Our experimental model seems to suggest that conversion of K~1~ to MK-4 did not take place in the presence of adequate levels of MK-4 in the feed, not even in the feed group with the lowest level of MK-4 (HSO). In the test groups the hepatic levels of MK-4 and MK-4O reflected the dietary intake of MK-4. Recently, a specific enzyme that converts K~1~ to MK-4 has been discovered and described ([@CIT0010]). The production capacity of this enzyme has not been compared with or distinguished from the menadione prenylation system ([@CIT0005]), so published evidence is as yet insufficient for a full quantitative picture of the various sources and pathways of synthesis in normally fed animals. MK-4O was in a different way dependent on the vitamin in the feed. The control group had the highest MK-4O levels in pancreas. This could be related to the supplementary K~3~ given to that group only. Liver and pancreas appears to use MK-4 in different ways; in liver 1/3 of MK-4 is converted to MK-4O while in pancreas almost all is as MK-4O. The content of K~1~ in liver was higher in the control group. The feed for this group contained more K~1~ and K~3~ was added.

Conclusion {#S0014}
==========

The chickens were in good health with good bone resistance without supplements of K~3~ in the feed but at least a natural content of 23 ng MK-4/g feed. Liver and pancreas appears to use MK-4 in different ways.
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